BCM
ENZN

Bridgeway Capital Management’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History

Bridgeway Capital Management’s Portfolio ENZN Stock Details ENZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-153,800
Closed -$72K – 1514
2016
Q1 		$72K Hold
153,800
– – ﹤0.01% 1387
2015
Q4 		$105K Hold
153,800
– – ﹤0.01% 1363
2015
Q3 		$149K Buy
153,800
+112,400
+271% +$138K ﹤0.01% 1352
2015
Q2 		$50K Buy
+41,400
New +$52.7K ﹤0.01% 1472
2013
Q4 		– Sell
-254,200
Closed -$427K – 1478
2013
Q3 		$427K Buy
254,200
+125,000
+97% +$231K 0.01% 1109
2013
Q2 		$258K Buy
+129,200
New +$378K 0.01% 1214

Other funds holding ENZN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
MCM
Monarch Capital Management Fort Wayne, Indiana $409M AUM 17.6% 1-Year Est. Return
CFA
CT Financial Advisors Chadds Ford, Pennsylvania $162M AUM 9.58% 1-Year Est. Return

Bridgeway Capital Management's ENZN Position: Q2 2016 in Review

Bridgeway Capital Management sold out of ENZON PHARMACEUTICALS INC (ENZN) in Q2 2016, closing a stake of 153,800 shares — an estimated $72K sold.

Bridgeway Capital Management first reported a position in ENZN in Q2 2013 and held it in 6 quarters. The position peaked at $427K in Q3 2013. 10 funds tracked by Wall St. Rank hold ENZN as of Q2 2016.

  • Bridgeway Capital Management reported no remaining ENZON PHARMACEUTICALS INC position as of Q2 2016 after selling out during the quarter.
  • Bridgeway Capital Management sold 153,800 ENZON PHARMACEUTICALS INC shares in Q2 2016, an estimated $72K.
  • Bridgeway Capital Management first reported a position in ENZON PHARMACEUTICALS INC in Q2 2013 and held it in 6 quarters.
  • Bridgeway Capital Management's ENZON PHARMACEUTICALS INC position peaked at $427K in Q3 2013.
  • 10 funds tracked by Wall St. Rank held ENZON PHARMACEUTICALS INC as of Q2 2016.

Based on Bridgeway Capital Management's 13F filing for Q2 2016, filed 15 Aug 2016.